Why the study?
The study was conducted to investigate the performance of HRCT versus 18F-FDG PET/CT for the diagnosis of pulmonary lymphangitic carcinomatosis.
Does 18F-FDG PET/CT improve the diagnosis of pulmonary lymphangitic carcinomatosis compared to high-resolution CT in patients with lung cancer?
Does 18F-FDG PET/CT improve the diagnosis of pulmonary lymphangitic carcinomatosis compared to high-resolution CT in patients with lung cancer?
Quantitative 18F-FDG PET/CT parameters outperform both qualitative PET/CT and HRCT for the diagnosis of pulmonary lymphangitic carcinomatosis in lung cancer patients.
No takes yet. Share an insight, caveat, or question.
May support quantitative PET/CT for PLC diagnosis in lung cancer; hypothesis-generating and requires prospective validation before practice change.
Jreige et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: